Market Domination Overtime hosts Julie Hyman and Josh Lipton preview several of the biggest market events and economic data that Wall Street will be following next week. Notable companies like ...

Amedisys Inc. (Nasdaq: AMED) experienced growth in home health during the fourth quarter of 2024, despite incurring merger-related costs from its pending ...

Amedisys, for the fourth quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, ...

For the quarter ended December 2024, Amedisys (AMED) reported revenue of $598.05 million, up 4.8% over the same period last year. EPS came in at $0.96, compared to $0.94 in the year-ago quarter. The ...

UnitedHealth Group and Amedisys outlined plans to divest a significant number of home health and hospice locations as they seek to close their $3.3 billion merger. In a court filing issued late ...

Mutual of America Capital Management LLC decreased its position in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by ...

However, UnitedHealth Group and Amedisys allege the lawsuit essentially ignores the companies' proposed divestiture package. The company didn’t identify which locations would be sold ...

(2) Adjusted EBITDA is defined as net (loss) income attributable to Amedisys, Inc. before net interest expense, provision for income taxes and depreciation and amortization, excluding certain ...

Amedisys shares have risen nearly 1% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $91.57, a fall of roughly 3% in the last 12 months.

BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported a fourth-quarter loss of $20.4 million, after reporting a profit in the same period a year earlier. On a ...